Archives

by in
Entry Author Date Location
More Drama for Sarepta as FDA Delays Duchenne Drug, Shares Tank 10/27/14 Boston
East Coast Biotech Roundup: PureTech, Celgene, Unum, Biogen & More 10/24/14 Boston
Try Then Buy? Sutro Deal Could Be Celgene’s Biggest Antibody Bet Yet 10/23/14 New York
New Atlas Startup Gets “Quartet” of Backers, $17M For Pain Drugs 10/23/14 Boston
Actavis Nabs Option to Buy Rhythm Pharma’s GI Drug For Diabetics 10/22/14 Boston
Proteon Cuts Price, Boosts Shares to Bag $61M in IPO 10/22/14 Boston
As Atlas Splits, Is There A Case To Make In Venture For Specialists? 10/22/14 National
Sanofi-Genzyme Joins $12M Round for T-Cell Therapy Startup, Unum 10/21/14 Boston
Boston’s Life Science Disruptors: The Photos 10/21/14 Boston
Cubist CEO Bonney Steps Down After 12-Year Stint 10/20/14 Boston
With Invesco’s Support, PureTech Boosts Power to Back Startups 10/20/14 Boston
VC Funding Still Robust as Year-to-Date Total Exceeds 2013 10/17/14 National
East Coast Biotech Roundup: Raze, Retrophin, Alnylam, & More 10/16/14 Boston
Selecta, Sharpening Focus, Gets $20M More to Make Biologics Safer 10/15/14 Boston
Venture Firms Turn Down Funding Volume, but Still Rockin’ in Q3 10/14/14 National
With $24M and Pharma Backing, Ex Epizyme Prez Aims to “Raze” Tumors 10/14/14 Boston
Untying the Knots in Big Data and Big Biology: Q&A with Andrew Su 10/13/14 San Diego
Six Takeaways from Boston’s Life Science Disruptors 10/13/14 Boston
Thync Adds Brain Electrodes to the Mix in Mobile Health Wearables 10/08/14 San Francisco
So Far, Little Proof That Digital Health Is Healthy. Does It Matter? 10/07/14 National
Smart-Bug Maker Synlogic Nabs $5M From Gates Foundation 10/07/14 Boston
East Coast Biotech Roundup: Intarcia, Atlas, Visterra, & More 10/06/14 Boston
Atlas Venture Splits: A Sharp Change in Less Than 18 Months 10/02/14 Boston
The Second Xconomy Boston Healthcare Summit: Request An Invitation 10/02/14 Boston
Alios’s Corporate Venture Backers Ride RSV (And Hep C) To Big Payday 10/01/14 San Francisco
Xconomy Boston’s Top Stories of Q3 2014: Editor’s Picks 10/01/14 Boston
One Week to Boston’s Life Science Disruptors—Check Out the Agenda 10/01/14 Boston
Well-Traveled Rhodes Leaves Epizyme For Atlas Venture Partnership 09/29/14 Boston
Ex-Elan Trio Grabs Their Former Employer’s Kinase Inhibitor Program 09/29/14 San Francisco
East Coast Biotech Roundup: GliaCure, Civitas, T2, & More 09/29/14 Boston
Page 2 of 88 « previous page · next page »